Showing results (121-130 of 172) with videos related to

Sort By:
Pageof 18
Anti-Cancer Drugs|August 1, 1996
Circadian variation in O6-methylguanine-DNA methyltransferase activity in mouse liverN Martineau-Pivoteau, C Cussac-Buchdahl, P Chollet, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Oxaliplatin activity against metastatic colorectal cancer. A phase II study of 5-day continuous venous infusion at circadian rhythm modulated rateF Levi, B Perpoint, C Garufi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1995
Lenograstim prevents morbidity from intensive induction chemotherapy in the treatment of inflammatory breast cancerB Chevallier, P Chollet, Y Merrouche, et al.
British Journal of Cancer|June 5, 2003
Neoadjuvant docetaxel for operable breast cancer induces a high pathological response and breast-conservation rateS Amat, P Bougnoux, F Penault-Llorca, et al.
Journal of Neuro-Oncology|February 24, 2001
Phase II trial of cystemustine, a new nitrosourea, as treatment of high-grade brain tumors in adultsH Roche, H Cure, A Adenis, et al.
NCI Monographs : a Publication of the National Cancer Institute|January 1, 1987
Treatment of advanced colorectal and gastric adenocarcinomas with 5-fluorouracil and high-dose folinic acidD Machover, E Goldschmidt, P Chollet, et al.
Pageof 18